The protective effect of berberine on β-cell lipoapoptosis

Journal of Endocrinological Investigation

Volumn 34, Issue 2, 2011, Pages 124-130

  Gao, N ^a   Zhao, T Y ^a   Li, X J ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Berberine; Lipoapoptosis; Palmitate; Peroxisome proliferator activated receptor ; cell

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; BERBERINE; GLUCOSE; INSULIN; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; IMMUNOCYTOCHEMISTRY; INSULIN RELEASE; LIPOTOXICITY; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION;

EID: 79957526254     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03347042     Document Type: Article

References (27)

1. Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D Jr. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 1984, 7: 491-502. (Pubitemid 14048622)
2. Lou DJ, Yang YW. The lipotoxicity and β cell apoptosis. Foreign Medical Sciences (Section of Internal Medicine) 2006, 33: 401-4.
3. Girard J. Fatty acids and beta cells. Diabetes Metab 2000, 26 (Suppl 3): 6-9.
4. Lupi R, Del Guerra S, Marselli L, et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004, 286: E560-7.
5. Kawai T, Hirose H, Seto Y, et al. Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma. Diabetes Res Clin Pract 2002, 56: 83-92. (Pubitemid 34226623)
6. Du YF, Yang LY. The protective effect of high expression of mouse PPAR-γ1 on γ-cell damage mediated by free fatty acid. Zhong Hua Diabetes Journal 2005, 12: 296-301.
7. Misra A, Kumar S, Kishore VN, Kumar A. The role of lipids in the development of diabetic microvascular complications: implications for therapy. Am J Cardiovasc Drugs 2003, 3: 325-38. (Pubitemid 37369366)
8. Heikkinen S, Auwerx J and Argmann CA. PPARgamma in human and mouse physiology. Biochim Biophys Acta 2007, 1771: 999-1013.
9. Saitoh Y, Chun-ping C, Noma K, Ueno H, Mizuta M, Nakazato M. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells. Diabetes Obes Metab 2008, 10: 564-73. (Pubitemid 351850900)
10. Wyne KL. Free fatty acids and type 2 diabetes mellitus. Am J Med 115 (Suppl 8A): 29S-36S, 2003.
11. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004, 25: 496-502.
12. Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 2006, 108: 109-15. (Pubitemid 44498992)
13. Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008, 93: 2559-65. (Pubitemid 352008520)
14. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004, 10: 1344-51. (Pubitemid 40022716)
15. Ravnskjaer K, Boergesen M, Rubi B, et al. Peroxisome proliferator- activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells. Endocrinology 2005, 146: 3266-76.
16. Dixon G, Nolan J, McClenaghan NH, Flatt PR, Newsholme P. Arachidonic acid, palmitic acid and glucose are important for the modulation of clonal pancreatic beta-cell insulin secretion, growth and functional integrity. Clin Sci (Lond) 2004, 106: 191-9. (Pubitemid 38223438)
17. Hao Y, Wang P, Wu J,Qiu QY. Effects of ginsenoside and berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG. Zhong Xi Yi Jie He Xue Bao 2008, 6: 278-82. (Pubitemid 351425299)
18. Meeran SM, Katiyar S, Katiyar SK. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 2008, 229: 33-43.
19. Kim JB, Lee KM, Ko E, et al. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med 2008, 74: 39-42. (Pubitemid 351251381)
20. Lin JP, Yang JS, Chang NW, et al. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 2007, 27: 3379-86.
21. Lin CC, Yang JS, Chen JT, et al. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 2007, 27: 3371-8.
22. Zheng L, Zhou Z, Tao D, Lan T. Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion. Sichuan Da Xue Xue Bao Yi Xue Ban 2003, 34: 452-4. (Pubitemid 37238447)
23. Xiao X, Liu J, Hu J, Li T, Zhang Y. Protective effect of protopine on the focal cerebral ischaemic injury in rats. Basic Clin Pharmacol Toxicol 2007, 101: 85-9. (Pubitemid 47094298)
24. Lin CY, Gurlo T, Haataja L, Hsueh WA, Butler PC. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 2005, 90: 6678-86. (Pubitemid 41759332)
25. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391: 79-82. (Pubitemid 28079218)
26. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004, 145: 5087-96. (Pubitemid 39551129)
27. Coll T, Jove M, Rodriguez-Calvo R, et al. Palmitate-mediated down-regulation of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006, 55: 2779-87. (Pubitemid 44923677)